PMC:7558914 / 1091-1328 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"40","span":{"begin":206,"end":214},"obj":"Species"},{"id":"51","span":{"begin":26,"end":44},"obj":"Chemical"},{"id":"52","span":{"begin":49,"end":68},"obj":"Chemical"},{"id":"53","span":{"begin":101,"end":119},"obj":"Chemical"},{"id":"54","span":{"begin":121,"end":133},"obj":"Chemical"},{"id":"55","span":{"begin":139,"end":158},"obj":"Chemical"},{"id":"68","span":{"begin":227,"end":236},"obj":"Disease"}],"attributes":[{"id":"A40","pred":"tao:has_database_id","subj":"40","obj":"Tax:9606"},{"id":"A51","pred":"tao:has_database_id","subj":"51","obj":"MESH:D006886"},{"id":"A52","pred":"tao:has_database_id","subj":"52","obj":"MESH:C558899"},{"id":"A53","pred":"tao:has_database_id","subj":"53","obj":"MESH:D006886"},{"id":"A54","pred":"tao:has_database_id","subj":"54","obj":"MESH:D017963"},{"id":"A55","pred":"tao:has_database_id","subj":"55","obj":"MESH:C558899"},{"id":"A68","pred":"tao:has_database_id","subj":"68","obj":"MESH:D011014"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Different combinations of hydroxychloroquine and lopinavir/ritonavir (46.7%) and triple therapy with hydroxychloroquine, azithromycin, and lopinavir/ritonavir (40%) were the most recommended treatments for patients with severe pneumonia."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T3","span":{"begin":227,"end":236},"obj":"Phenotype"}],"attributes":[{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"Different combinations of hydroxychloroquine and lopinavir/ritonavir (46.7%) and triple therapy with hydroxychloroquine, azithromycin, and lopinavir/ritonavir (40%) were the most recommended treatments for patients with severe pneumonia."}

{"project":"LitCovid-sentences","denotations":[{"id":"T10","span":{"begin":0,"end":237},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Different combinations of hydroxychloroquine and lopinavir/ritonavir (46.7%) and triple therapy with hydroxychloroquine, azithromycin, and lopinavir/ritonavir (40%) were the most recommended treatments for patients with severe pneumonia."}